MedTrace Logo

DualSculpting the Abdomen Using CoolSculpting

NCT02941146 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-12-06

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and efficacy of abdominal DualSculpting with CoolAdvantage applicators.

Conditions

  • Body Fat Disorder

Interventions

DEVICE

The ZELTIQ System

The CoolSculpting System will be used to perform the treatments with the CoolAdvantage family of applicators.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-03-29
Completion
2017-03-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02941146 on ClinicalTrials.gov